Document Detail


The Role of Cytokines in the Initiation and Maintenance of Chronic Pain.
MedLine Citation:
PMID:  12677247     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Recent advancements in the pain field have identified a central nervous system (CNS) neuroimmune response that may act as the driving force for neuronal hypersensitivity, the pathological correlate to chronic pain following peripheral nerve injury. Neuroimmune activation involves the activation of nonneuronal cells such as endothelial and glial cells, which when stimulated leads to enhanced production of a host of inflammatory mediators, such as cytokines. The central production of proinflammatory cytokines, such as interleukin-1beta (IL-1beta), IL-6 and tumor necrosis factor have been found to play a key role in the propagation of persistent pain states. In addition, chemotactic cytokines, chemokines, have also been recently identified in the CNS neuroimmune cascade that ensues after injury to a peripheral nerve. The extravasation of leukocytes from the blood to the site of perceived injury is defined as the neuroinflammatory aspect of this cascade. Chemokines directly control this leukocyte transmigration process. They are synthesized at the site of injury and establish a concentration gradient through which immune cells migrate. Recent studies have demonstrated leukocyte trafficking into the CNS following peripheral nerve or lumbar nerve root injury. With the use of selective cytokine inhibitors and neutralizing antibodies, tactile and thermal hypersensitivity is attenuated in animal models of neuropathy. A further understanding of the role of nonneuronal cells, the physiological mechanisms of CNS cytokines and chemokines, and their relevance to neuro- immune activation and neuroinflammatory processes may lead to the development of novel pharmacological agents for the treatment and prevention of chronic pain. (c) 2002 Prous Science. All rights reserved.
Authors:
Maria D. Rutkowski; Joyce A. DeLeo
Related Documents :
18240307 - Interleukin 15 expression in the cns: blockade of its activity prevents glial activatio...
18673197 - The blood-central nervous system barriers actively control immune cell entry into the c...
22082587 - Clinical application of a systems model of apoptosis execution for the prediction of co...
21320787 - Pattern of activin a and follistatin release in a sheep model of cardiopulmonary bypass.
17894897 - Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer ...
18573897 - Characterization of human cellular immune responses to novel mycobacterium tuberculosis...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Drug news & perspectives     Volume:  15     ISSN:  0214-0934     ISO Abbreviation:  Drug News Perspect.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2003-Apr-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809164     Medline TA:  Drug News Perspect     Country:  -    
Other Details:
Languages:  ENG     Pagination:  626-632     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists.
Next Document:  Pathophysiology of Diabetic Retinopathy.